Sam Nasser, MD in Troy, MI - Medicare Orthopaedic Surgery

Sam Nasser, MD is a medicare enrolled "Orthopaedic Surgery" physician in Troy, Michigan. His current practice location is 1560 E Maple Rd, Suite 200, Troy, Michigan. You can reach out to his office (for appointments etc.) via phone at (248) 581-5846.

Sam Nasser is licensed to practice in Michigan (license number 4301046341) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1578500666.

Contact Information

	Sam Nasser, MD
	1560 E Maple Rd, Suite 200, Troy, MI 48083-1138
	(248) 581-5846
	(248) 581-5642

Physician's Profile

Full Name	Sam Nasser
Gender	Male
Speciality	Orthopaedic Surgery
Location	1560 E Maple Rd, Troy, Michigan
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1578500666
Provider Enumeration Date: 05/31/2006
Last Update Date: 10/27/2016

Medicare PECOS Information:

PECOS PAC ID: 0244139772
Enrollment ID: I20040611000636

Medical Identifiers

Medical identifiers for Sam Nasser such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578500666	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	4301046341 (Michigan)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sam Nasser allows following entities to bill medicare on his behalf.

Entity Name	Vhs Physicians Of Michigan
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073827101 PECOS PAC ID: 8921289760 Enrollment ID: O20110225000849

News Archive

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

Genentech, Inc., a member of the Roche Group, today announced that information submitted by the company to the U.S. Food and Drug Administration (FDA) during the review of the supplemental Biologics License Applications (sBLAs) for Avastin (bevacizumab) for previously untreated (first-line) advanced HER2-negative breast cancer has been deemed a major amendment.

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.

Gen-Probe invests $50M in Pacific Biosciences

Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.

Children with autism spectrum disorder need continued support

9 out of 10 preschool children with autism still have major difficulties within the autism field at school age, despite having received early intervention. A majority of the parents stated that the children do not receive sufficient support at school.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sam Nasser is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sam Nasser, MD 1560 E Maple Rd, Suite 400 - Credentialing, Troy, MI 48083-1138 Ph: (248) 581-5846	Sam Nasser, MD 1560 E Maple Rd, Suite 200, Troy, MI 48083-1138 Ph: (248) 581-5846

News Archive

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Gen-Probe invests $50M in Pacific Biosciences

Children with autism spectrum disorder need continued support

Orthopaedic Surgery Doctors in Troy, MI

Dr. Blake Fenkell, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6905 Rochester Rd, Troy, MI 48085 Phone: 248-828-1100 Fax: 248-498-7594
Michael Andreas Flierl, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Kirts Blvd, Ste 160, Troy, MI 48084 Phone: 248-244-9426 Fax: 248-244-9495
Dr. Charles C Stroud, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4550 Investment Dr Ste 240, Troy, MI 48098 Phone: 248-792-9881 Fax: 248-792-9895
Dr. Gregory P Nowinski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Kirts Blvd, Ste 160, Troy, MI 48084 Phone: 248-244-9426 Fax: 248-244-9495
Dr. Tyrone W Cobb, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 41069 Dequindre Rd, Ste 103, Troy, MI 48085 Phone: 248-828-1080 Fax: 248-828-1028
Dr. Donald M Knapke, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Kirts Blvd, Ste 160, Troy, MI 48084 Phone: 248-244-9426 Fax: 248-244-9495
Matthew John Yousif, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 W Big Beaver Rd Ste 115, Troy, MI 48084 Phone: 248-329-0711

Sam Nasser, MD - Medicare Orthopaedic Surgery in Troy, MI

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Gen-Probe invests $50M in Pacific Biosciences

Children with autism spectrum disorder need continued support

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Gen-Probe invests $50M in Pacific Biosciences

Children with autism spectrum disorder need continued support

Orthopaedic Surgery Doctors in Troy, MI